WEBULL
News
ABVX
130.98
-5.32%
-7.36
– Abivax SA American Depositary Shares call volume above normal and directionally bullish
TipRanks · 12/30/2025 19:45
Weekly Report: what happened at ABVX last week (1222-1226)?
Weekly Report · 12/29/2025 09:29
Abivax rumored to attract interest from Eli Lilly, La Tribune says
TipRanks · 12/24/2025 13:15
5 Stocks That Moved the Most in 2025 – What Lies Ahead
TipRanks · 12/23/2025 21:18
These Are the Most and Least Likely Biotech Takeover Targets for 2026
TipRanks · 12/23/2025 19:37
Here are the most and least likely M&A targets in biotech, according to Truist
Seeking Alpha · 12/23/2025 18:26
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and Integra Lifesciences (IART)
TipRanks · 12/23/2025 12:20
Abivax: Here's Why Eli Lilly Could Want Its Oral Ulcerative Colitis Therapy
Seeking Alpha · 12/23/2025 11:41
Abivax is the top performing biotechnology stock YTD
Seeking Alpha · 12/22/2025 21:07
UniFirst, Adeia, Cytokinetics And Other Big Stocks Moving Higher On Monday
Benzinga · 12/22/2025 15:56
Abivax rises 16.1%
TipRanks · 12/22/2025 15:05
Top 10 healthcare stocks according to YTD performance, as the sector holds steady
Seeking Alpha · 12/22/2025 14:59
BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Velo3D, Fastenal
Reuters · 12/22/2025 14:24
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, GE Vernova, copper miners
Reuters · 12/22/2025 12:39
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 12/22/2025 12:05
Why Is Abivax (ABVX) Stock Rallying Today? Big Pharma Takeover Buzz Builds
TipRanks · 12/22/2025 11:34
Why Clearwater Analytics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Benzinga · 12/22/2025 11:00
Biggest stock movers Monday: ABVX, RKLB, and more
Seeking Alpha · 12/22/2025 09:54
Weekly Report: what happened at ABVX last week (1215-1219)?
Weekly Report · 12/22/2025 09:29
BUZZ-Abivax jumps on media reports of Eli Lilly takeover bid
Reuters · 12/22/2025 09:01
More
Webull provides a variety of real-time ABVX stock news. You can receive the latest news about Abivax S.A. through multiple platforms. This information may help you make smarter investment decisions.
About ABVX
Abivax SA is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of anti-viral compounds and therapeutic vaccines against severe and life threatening infectious diseases. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The Company's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.